| Oct 14 |
GE HealthCare introduces easy-to-use, easy-to-learn, easy-to-diagnose Versana Premier multi-purpose ultrasound system
|
| Oct 10 |
Jim Cramer Likes Reddit Very Much, Calls Accenture A 'Great Buy'
|
| Oct 9 |
GE HealthCare Accelerates Artificial Intelligence Adoption With New Offering to Advance Enterprise Imaging
|
| Oct 8 |
Dow Jones Giant Eyes Possible $10 Billion Spinoff; Is It The Next GE?
|
| Oct 8 |
GE HealthCare to announce third quarter 2024 results on October 30, 2024
|
| Oct 7 |
GE HealthCare takes role in consortium for cancer care for patients in Europe
|
| Oct 7 |
GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe
|
| Oct 7 |
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
|
| Sep 30 |
GE Healthcare Stock After Approval of New Test Agent
|
| Sep 27 |
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
|
